Publish
Home
Live
new
RH Journal
ResearchCoin
Grants
Funding
Browse
Journals
Hubs
Tools
Lab Notebook
Beta
Reference Manager
Resources
Verify Identity
Community
Support
About
Terms
Privacy
Issues
Docs
Paper
Log in
Sign up
Paper
0
Paper
Conversation
Grants
Reviews
Document
Download
Flag content
0
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Internal Medicine
Urology
Cardiology And Cardiovascular Medicine
Show More
Authors
Bryan Williams
,
Thomas MacDonald
S. Morant
,
David Webb
,
Peter Sever
,
Gordon McInnes
,
Ian Ford
,
J. CRUICKSHANK
,
Mark Caulfield
,
Jackie Salsbury
,
Isla Mackenzie
,
Sandosh Padmanabhan
+10 authors
,
Morris Brown
Journal
The Lancet
Published
Sep 20, 2015
DOI
10.1016/s0140-6736(15)00257-3
Show more
Save
Tip
Document
Download
Flag content
0
Tip
Save
Document
Download
Flag content
Paper
Conversation
Grants
Reviews
There was an error loading this page.